Stock NVO NOVO NORDISK A/S
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Novo Nordisk A/S Nyse

Equities

NVO

US6701002056

Real-time Estimate Cboe BZX
Other stock markets
 01:09:43 2024-05-03 pm EDT 		5-day change 1st Jan Change
123.2 USD -0.67% Intraday chart for Novo Nordisk A/S -2.76% +19.24%
06:19pm Top Midday Stories: Apple's Dividend, Buybacks Announcements; Amgen Obesity Drug Trial Results; Exxon Completes Pioneer Acquisition MT
05:34pm Novo Nordisk: share price falls, analyst adjusts target CF

Evolution of the average Target Price on Novo Nordisk A/S

Price target over the last 5 years

History of analyst recommendation changes

46177b6.RsEi_ScuoXHwDuaQywpxn2A-dKjEXeBxFKP5lowLrwU.EexqvmgX-DC1N6fbgnNFqCJSLOaMcIwTLJeKwPZK1mEupmewTW35N8lv3g~b12554c1964922ad1c9fb77d9ae894e7

Analyst Recommendations on Novo Nordisk A/S

NOVO NORDISK : DZ Bank sticks Neutral ZD
NOVO NORDISK : Stifel lowers target slightly CF
NOVO NORDISK : Buy rating from Deutsche Bank ZD
Novo Nordisk drops 5% after rival Amgen teases weight-loss drug data RE
NOVO NORDISK : JP Morgan gives a Buy rating ZD
NOVO NORDISK : Q1 beat; guidance upgrade but sentiment nonetheless dampened by price reductions Alphavalue
NOVO NORDISK : Gets a Buy rating from Barclays ZD
NOVO NORDISK : UBS gives a Neutral rating ZD
NOVO NORDISK : JP Morgan gives a Buy rating ZD
NOVO NORDISK : Receives a Sell rating from Jefferies ZD
NOVO NORDISK : UBS sticks Neutral ZD
NOVO NORDISK : JP Morgan gives a Buy rating ZD
NOVO NORDISK : Bernstein maintains a Buy rating ZD
BMO Capital Starts Novo Nordisk With Outperform Rating, $163 Price Target MT
NOVO NORDISK : UBS sticks Neutral ZD
NOVO NORDISK : Barclays maintains a Buy rating ZD
NOVO NORDISK : Berenberg remains Neutral ZD
NOVO NORDISK : Novo’s bag is full of pearls! Alphavalue
NOVO NORDISK : Barclays reiterates its Buy rating ZD
NOVO NORDISK : UBS sticks Neutral ZD
NOVO NORDISK : JP Morgan reaffirms its Buy rating ZD
NOVO NORDISK : Deutsche Bank reiterates its Buy rating ZD
NOVO NORDISK : Novo’s got a strong arsenal to go the distance Alphavalue
NOVO NORDISK : Buy rating from Barclays ZD
NOVO NORDISK : Receives a Buy rating from Deutsche Bank ZD
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
873.1 DKK
Average target price
906.2 DKK
Spread / Average Target
+3.79%
High Price Target
1,120 DKK
Spread / Highest target
+28.28%
Low Price Target
530 DKK
Spread / Lowest Target
-39.30%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Novo Nordisk A/S

alphavalue Abhishek Raval
BARCLAYS Emily Field
JEFFERIES Peter Welford
JPMORGAN Richard Vosser
UBS Jo Walton
BERNSTEIN RESEARCH Florent Cespedes
BMO Capital
BERENBERG Kerry Holford
DEUTSCHE BANK RESEARCH Emmanuel Papadakis
Cantor Fitzgerald
DZ BANK Elmar Kraus
TD Cowen
Stifel Nicolaus
ODDO BHF
Berenberg Bank
CREDIT SUISSE Lorenzo Biasio
GOLDMAN SACHS Keyur Parekh
Morgan Stanley
BNP Paribas Exane
JPMorgan Chase
Guggenheim
Bryan, Garnier & Co.
Deutsche Bank Securities
DEUTSCHE BANK Emmanuel Papadakis
Liberum Capital
KEPLER CHEUVREUX David Evans
HSBC Stephen McGarry
INDEPENDENT RESEARCH Tobias Gottschalt
BANK OF AMERICA (BOFA) Sachin Jain

Ratings for Novo Nordisk A/S

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. NOVO B Stock
  4. NVO Stock
  5. Consensus Novo Nordisk A/S